Clinical Trials (Industry/Regulatory Perspective)
From FDA’s Draft Guidance for Industry: General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products, Dec 2014 For conditions where the disease progression and response to intervention…